Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-21T06:11:56.322Z Has data issue: false hasContentIssue false

P03-123 - Validation of the Spanish Version of the Subjective Well-Being Under Neuroleptic Scale (SWN) in Patients with Schizophrenia

Published online by Cambridge University Press:  17 April 2020

J. Sanjuan
Affiliation:
Faculty of Medicine, University of Valencia, CIBERSAM, Valencia, Spain
J.M. Haro
Affiliation:
Parc Sanitari Sant Joan de Deu, Sant Boi de Llobregat, Spain
J. Maurino
Affiliation:
Medical Department, AstraZeneca Spain, Madrid, Spain
T. Diez
Affiliation:
Medical Department, AstraZeneca Spain, Madrid, Spain
J. Ballesteros
Affiliation:
Department of Neuroscience-Psychiatry, University of the Basque Country, Leioa, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective

To assess the psychometric properties of the Spanish version of the SWN scale, an instrument which evaluates the subjective experience of psychotic patients towards neuroleptic treatment.

Methods

A validation study (feasibility, reliability, and validity) was conducted in 20 psychiatric centers. Patients were evaluated with the PANSS, the CGI severity scale and the SWN-20. A re-test was conducted one week after baseline. The study included clinically stabilized outpatients diagnosed with schizophrenia (DSM-IV-TR criteria) who were on treatment as usual. The SWN used in this study consists of 20 questions answered on a 6-point Likert scale. The total score ranges from 20 to 120 points (higher scores indicating better well-being). The original version was back-translated and a focus group was conducted to improve the comprehension of the items.

Results

97 patients were included. Seventy-two percent of them (70) were male. Mean age was 35 years (SD = 10.0). Mean SWN total score: 83.5 (SD = 14.0). Internal homogeneity: 0.86. Test-retest in clinically stable patients was 0.89. SWN correlated significantly with the PANSS, but not with the DAI-10. Patients with none-mild clinical affectation had higher SWN scores, indicating a better subjective well-being, and vice versa.

Conclusions

The subjective experience of psychotic patients towards treatment is a key factor in therapeutic adherence, quality of life, and clinical outcome. The Spanish version of the SWN scale showed good psychometric properties in a sample of schizophrenic stabilized outpatients. SWN scale constitutes a valuable addition to evaluate patients’ subjective well-being.

Type
Psychotic disorders / Schizophrenia
Copyright
Copyright © European Psychiatric Association 2010
Submit a response

Comments

No Comments have been published for this article.